Pharma Mar, S.A. (BME:PHM)
88.70
+0.10 (0.11%)
Sep 4, 2025, 9:13 AM CET
Pharma Mar Market Cap
Pharma Mar has a market cap or net worth of €1.56 billion as of September 3, 2025. Its market cap has increased by 124.08% in one year.
Market Cap
1.56B
Enterprise Value
1.48B
Revenue
189.27M
Ranking
n/a
PE Ratio
37.07
Stock Price
€88.70
Market Cap Chart
Since November 2, 2015, Pharma Mar's market cap has decreased from 1.80B to 1.56B, a decrease of -13.45%. That is a compound annual growth rate of -1.46%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 2, 2025 | 1.49B | 7.55% |
Dec 31, 2024 | 1.39B | 88.09% |
Dec 29, 2023 | 738.49M | -36.23% |
Dec 30, 2022 | 1.16B | 12.13% |
Dec 30, 2021 | 1.03B | -21.36% |
Dec 31, 2020 | 1.31B | 66.28% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Nov 2, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Grifols | 7.20B |
Laboratorios Farmaceuticos Rovi | 2.98B |
Almirall | 2.41B |
Faes Farma | 1.32B |
Clínica Baviera | 734.14M |
Laboratorio Reig Jofre | 226.24M |
Atrys Health | 214.09M |
Prim, S.A. | 207.56M |